Webinars as a Catalyst for Family Office Engagement
Explore how webinars are reshaping engagement strategies for family offices in 2026, enhancing collaboration and knowledge sharing.
Reprogramming the Course of Cancer and Diabetes
Genprex, Inc is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options.
What they will learn from this webinar
How Genprex is bridging critical gaps in modern medicine by providing new treatment options to patients with cancer and diabetes
The Company’s oncology program and its modern combinational treatment approach to fight cancer
How its diabetes program could eliminate the need for insulin in diabetic patients
At Genprex, they believe their therapies offer a strong value proposition to the market to address unmet medical needs and save lives.
Join the discussion
Comments are open to signed-in members. Sign in to add yours, or apply to join the network.
Sign in Apply for FON+